Published in Dig Dis Sci on November 01, 2006
Evidence-based clinical practice guidelines for irritable bowel syndrome. J Gastroenterol (2014) 2.30
Overlap of Erosive and Non-erosive Reflux Diseases With Functional Gastrointestinal Disorders According to Rome III Criteria. J Neurogastroenterol Motil (2010) 1.33
Prediction of response to PPI therapy and factors influencing treatment outcome in patients with GORD: a prospective pragmatic trial using pantoprazole. BMC Gastroenterol (2011) 1.11
Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome. World J Gastroenterol (2013) 1.05
Irritable Bowel Syndrome and Co-morbid Gastrointestinal and Extra-gastrointestinal Functional Syndromes. J Neurogastroenterol Motil (2010) 1.01
Overlap of dyspepsia and gastroesophageal reflux in the general population: one disease or distinct entities? Neurogastroenterol Motil (2011) 1.01
Pharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome. Gut Liver (2011) 0.99
Gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS)--is it one disease or an overlap of two disorders? Dig Dis Sci (2008) 0.99
Analysis of the gastrointestinal symptoms of uninvestigated dyspepsia and irritable bowel syndrome. Gut Liver (2009) 0.99
Bacterial overgrowth and irritable bowel syndrome: unifying hypothesis or a spurious consequence of proton pump inhibitors? Am J Gastroenterol (2008) 0.97
Overlapping gastroesophageal reflux disease and irritable bowel syndrome: increased dysfunctional symptoms. World J Gastroenterol (2010) 0.97
Patients with irritable bowel syndrome are more burdened by co-morbidity and worry about serious diseases than healthy controls--eight years follow-up of IBS patients in primary care. BMC Public Health (2013) 0.93
Influence of psychological distress on characteristics of symptoms in patients with GERD: the role of IBS comorbidity. Dig Dis Sci (2008) 0.86
Current advances in the diagnosis and treatment of nonerosive reflux disease. Gastroenterol Res Pract (2013) 0.83
Irritable bowel syndrome and gastroesophageal reflux disease in primary care: is there a link? Dig Dis Sci (2008) 0.81
Proton pump inhibitor therapy does not affect hydrogen production on lactulose breath test in subjects with IBS. Dig Dis Sci (2009) 0.81
Influence of irritable bowel syndrome on treatment outcome in gastroesophageal reflux disease. World J Gastroenterol (2011) 0.80
Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD. Am J Gastroenterol (2016) 0.77
Gastroesophageal Reflux Disease and Helicobacter pylori: What May Be the Relationship? J Neurogastroenterol Motil (2010) 0.77
Exploring the agreement between diagnostic criteria for IBS in primary care in Greece. BMC Res Notes (2008) 0.75
Symptom characteristics and psychosomatic profiles in different spectrum of gastroesophageal reflux disease. Gut Liver (2013) 0.75
The Effect of Peripheral CRF Peptide and Water Avoidance Stress on Colonic and Gastric Transit in Guinea Pigs. Yonsei Med J (2017) 0.75
Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51
Functional bowel disorders and functional abdominal pain. Gut (1999) 7.63
Non-colonic features of irritable bowel syndrome. Gut (1986) 5.48
Irritable bowel syndrome in the general population. BMJ (1992) 5.26
Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med (1982) 5.07
Symptoms in gastro-oesophageal reflux disease. Lancet (1990) 4.10
Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology (1995) 3.86
The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther (2003) 3.41
Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns. Gut (1983) 2.93
Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology (1990) 2.75
Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol (2005) 2.68
Prevalence, clinical spectrum and health care utilization of gastro-oesophageal reflux disease in a Chinese population: a population-based study. Aliment Pharmacol Ther (2003) 2.30
A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol (2000) 2.27
Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol (2003) 2.21
Symptoms of gastro-oesophageal reflux: prevalence, severity, duration and associated factors in a Spanish population. Aliment Pharmacol Ther (2004) 2.13
Prevalence of irritable bowel syndrome: a community survey. Br J Gen Pract (2004) 2.03
The association between non-ulcer dyspepsia and other gastrointestinal disorders. Scand J Gastroenterol (1985) 2.01
Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population. Ann Med (1995) 1.97
Lower frequency of MMC is found in IBS subjects with abnormal lactulose breath test, suggesting bacterial overgrowth. Dig Dis Sci (2002) 1.90
The prevalence of gastro-oesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms. Aliment Pharmacol Ther (2000) 1.64
Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population. Gut (1998) 1.57
The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an asian urban community. Am J Gastroenterol (2004) 1.47
Clinical outcome of laparoscopic antireflux surgery for patients with irritable bowel syndrome. Surg Endosc (2004) 1.43
Transit through the proximal colon influences stool weight in the irritable bowel syndrome. Gastroenterology (1992) 1.41
Prevalence, severity and associated features of gastro-oesophageal reflux and dyspepsia: a population-based study. N Z Med J (2000) 1.34
Prevalence of gastroesophageal reflux in elderly patients in a primary care setting. Am J Gastroenterol (1991) 1.27
The prevalence of symptoms suggestive of esophageal disorders. Scand J Gastroenterol (1991) 1.26
Heartburn in Belgium: prevalence, impact on daily life, and utilization of medical resources. Eur J Gastroenterol Hepatol (2002) 1.18
Upper gastrointestinal and mental symptoms in the irritable bowel syndrome. Scand J Gastroenterol (1985) 1.16
Prevalence and impact of symptoms suggestive of gastroesophageal reflux disease. Dig Dis Sci (1999) 1.14
Origin of gas retention and symptoms in patients with bloating. Gastroenterology (2005) 1.13
Dyspeptic symptoms and gastric emptying in the irritable bowel syndrome. Am J Gastroenterol (2002) 1.12
Gastro-esophageal reflux disease in northwestern Tabriz, Iran. Indian J Gastroenterol (2003) 1.07
Irritable bowel syndrome in France: a common, debilitating and costly disorder. Eur J Gastroenterol Hepatol (2004) 1.06
Increased prevalence of irritable bowel syndrome in patients with gastroesophageal reflux. J Clin Gastroenterol (2002) 1.05
Review article: approaches to endoscopic-negative reflux disease: part of the GERD spectrum or a unique acid-related disorder? Aliment Pharmacol Ther (2004) 1.04
Characteristics of small bowel motility in patients with irritable bowel syndrome and normal humans: an Oriental study. Clin Sci (Lond) (1998) 1.01
Irritable bowel syndrome in patients with dyspepsia: a community-based study in southern Europe. Eur J Gastroenterol Hepatol (1999) 1.00
Altered esophageal pain threshold in irritable bowel syndrome. Dig Dis Sci (1993) 0.95
Gastro-oesophageal reflux in the irritable bowel syndrome. Gut (1986) 0.92
Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria. Gastroenterol Clin Biol (2004) 0.91
Gastrointestinal motility in patients with irritable bowel syndrome studied by using radiopaque markers. Scand J Gastroenterol (1999) 0.86
Gastrointestinal motility in patients with the irritable bowel syndrome. Scand J Gastroenterol Suppl (1987) 0.86
Abnormalities of GI transit in bloated irritable bowel syndrome: effect of bran on transit and symptoms. Am J Gastroenterol (2002) 0.85
Factors that influence therapeutic outcomes in symptomatic gastroesophageal reflux disease. Am J Gastroenterol (2003) 0.85
Irritable bowel, smoking and oesophageal acid exposure: an insight into the nature of symptoms of gastro-oesophageal reflux. Aliment Pharmacol Ther (2004) 0.82
[Surgery of reflux esophagitis--a renaissance]. Ther Umsch (2001) 0.75
The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med (2006) 3.30
Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity. Am J Physiol Gastrointest Liver Physiol (2005) 1.96
Pathogen-specific risk of celiac disease following bacterial causes of foodborne illness: a retrospective cohort study. Dig Dis Sci (2013) 1.47
The degree of breath methane production in IBS correlates with the severity of constipation. Am J Gastroenterol (2007) 1.46
Methane production during lactulose breath test is associated with gastrointestinal disease presentation. Dig Dis Sci (2003) 1.46
Rifaximin versus other antibiotics in the primary treatment and retreatment of bacterial overgrowth in IBS. Dig Dis Sci (2007) 1.35
A systematic review of diagnostic tests for small intestinal bacterial overgrowth. Dig Dis Sci (2008) 1.28
Methane and the gastrointestinal tract. Dig Dis Sci (2009) 1.24
Neomycin improves constipation-predominant irritable bowel syndrome in a fashion that is dependent on the presence of methane gas: subanalysis of a double-blind randomized controlled study. Dig Dis Sci (2006) 1.24
Measurement of gastrointestinal transit. Dig Dis Sci (2005) 1.20
Abnormal breath testing in IBS: a meta-analysis. Dig Dis Sci (2010) 1.20
The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome. Dig Dis Sci (2012) 1.15
Evaluating breath methane as a diagnostic test for constipation-predominant IBS. Dig Dis Sci (2009) 1.06
Methanobrevibacter smithii is the predominant methanogen in patients with constipation-predominant IBS and methane on breath. Dig Dis Sci (2012) 1.04
Role of Cytolethal Distending Toxin in Altered Stool Form and Bowel Phenotypes in a Rat Model of Post-infectious Irritable Bowel Syndrome. J Neurogastroenterol Motil (2012) 1.02
Methane on breath testing is associated with constipation: a systematic review and meta-analysis. Dig Dis Sci (2011) 1.02
Intestinal methane production in obese individuals is associated with a higher body mass index. Gastroenterol Hepatol (N Y) (2012) 1.01
Bacteria and irritable bowel syndrome: the evidence for small intestinal bacterial overgrowth. Curr Gastroenterol Rep (2006) 1.01
Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance. Ther Adv Chronic Dis (2013) 0.99
Carbohydrate-binding proteins in cancer, and their ligands as therapeutic agents. Trends Mol Med (2002) 0.98
Antibiotics for the treatment of irritable bowel syndrome. Gastroenterol Hepatol (N Y) (2011) 0.97
Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome. BMC Gastroenterol (2012) 0.97
Apple sauce improves detection of esophageal motor dysfunction during high-resolution manometry evaluation of dysphagia. Dig Dis Sci (2010) 0.96
Lactose intolerance and the role of the lactose breath test. Am J Gastroenterol (2010) 0.95
Evaluation of harm in the pharmacotherapy of irritable bowel syndrome. Am J Med (2012) 0.94
Breath testing to evaluate lactose intolerance in irritable bowel syndrome correlates with lactulose testing and may not reflect true lactose malabsorption. Am J Gastroenterol (2003) 0.94
Measuring response in the gastrointestinal tract in systemic sclerosis. Curr Opin Rheumatol (2013) 0.93
Gender distribution in irritable bowel syndrome is proportional to the severity of constipation relative to diarrhea. Gend Med (2010) 0.93
Estimating the contribution of acute gastroenteritis to the overall prevalence of irritable bowel syndrome. J Neurogastroenterol Motil (2012) 0.90
A combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome patients with methane on lactulose breath test. J Clin Gastroenterol (2010) 0.90
A 14-day elemental diet is highly effective in normalizing the lactulose breath test. Dig Dis Sci (2004) 0.90
ICC density predicts bacterial overgrowth in a rat model of post-infectious IBS. World J Gastroenterol (2010) 0.89
Acute and chronic histological changes of the small bowel secondary to C. jejuni infection in a rat model for post-infectious IBS. Dig Dis Sci (2011) 0.88
Intestinal Methanobrevibacter smithii but not total bacteria is related to diet-induced weight gain in rats. Obesity (Silver Spring) (2013) 0.87
Pathogen-specific risk of chronic gastrointestinal disorders following bacterial causes of foodborne illness. BMC Gastroenterol (2013) 0.87
Esophageal motor dysfunction and gastroesophageal reflux are prevalent in lung transplant candidates. Ann Thorac Surg (2010) 0.86
A high-resolution view of achalasia. J Clin Gastroenterol (2009) 0.85
IBS subjects with methane on lactulose breath test have lower postprandial serotonin levels than subjects with hydrogen. Dig Dis Sci (2004) 0.84
Bacterial concepts in irritable bowel syndrome. Rev Gastroenterol Disord (2005) 0.82
Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies. J Clin Gastroenterol (2011) 0.82
Relationships among the lactulose breath test, intestinal gas volume, and gastrointestinal symptoms in patients with irritable bowel syndrome. Dig Dis Sci (2011) 0.81
Factor analysis demonstrates a symptom cluster related to methane and non-methane production in irritable bowel syndrome. J Clin Gastroenterol (2011) 0.81
Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome. Scand J Gastroenterol (2015) 0.81
Severity of dyspeptic symptoms correlates with delayed and early variables of gastric emptying. Dig Dis Sci (2012) 0.81
Irritable bowel syndrome and small intestinal bacterial overgrowth. J Clin Gastroenterol (2010) 0.81
Proton pump inhibitor therapy does not affect hydrogen production on lactulose breath test in subjects with IBS. Dig Dis Sci (2009) 0.81
"Pre-cebo": an unrecognized issue in the interpretation of adequate relief during irritable bowel syndrome drug trials. J Clin Gastroenterol (2012) 0.80
Antibiotics for irritable bowel syndrome: rationale and current evidence. Curr Gastroenterol Rep (2012) 0.79
Prevention of traveler's diarrhea: a call to reconvene. Clin Infect Dis (2008) 0.79
Polycystic ovary syndrome is associated with an increased prevalence of irritable bowel syndrome. Dig Dis Sci (2009) 0.79
Antibiotic prophylaxis prevents the development of a post-infectious phenotype in a new rat model of post-infectious IBS. Dig Dis Sci (2011) 0.76
The effect of rifaximin on gut flora and Staphylococcus resistance. Dig Dis Sci (2013) 0.76
Topical bethanechol for the improvement of esophageal dysmotility: a pilot study. Ann Otol Rhinol Laryngol (2013) 0.76
Recorded lower esophageal pressures as a function of electronic sleeve placement and location of gastric pressure measurement in patients with hiatal hernia. J Neurogastroenterol Motil (2013) 0.75
Visceroptosis of the bowel in the hypermobility type of Ehlers-Danlos syndrome: presentation of a rare manifestation and review of the literature. Eur J Med Genet (2012) 0.75
Do antibiotics influence IBS? Am J Gastroenterol (2002) 0.75
Identifying and testing candidate genetic polymorphisms in irritable bowel syndrome: association with TNFSF15 and tumor necrosis factor-α Ann Gastroenterol (2013) 0.75
Gastroesophageal reflux reported on esophagram does not correlate with pH monitoring and high-resolution esophageal manometry. Am Surg (2014) 0.75
Serum sTREM-1 as a surrogate marker of treatment outcome in patients with peptic ulcer disease. Dig Dis Sci (2011) 0.75
History of tonsillectomy is associated with irritable bowel syndrome. J Clin Gastroenterol (2011) 0.75